| ICG | Indocyanine green (ICG) |
| JQ1 | Thienotriazolodiazepine |
| BMS (BMS986205) | Linrodostat |
| ICD | Immunogenic cell death |
| PTT | Photothermal therapy |
| CpG | cytosine-guanine dinucleotides |
| PD-1/PD-L1 | Programmed cell death-1/Programmed cell death ligand-1 |
| IDO-1 | Indoleamine 2,3-dioxygenase 1 |
| MIRDs | Polyphenols coating ICG loaded magnetic nanoparticles |
| DPA-PEG | Dopamine-Poly(ethylene glycol) |
| R837 | Near-infrared heptamethine cyanine dye |
| NC | Nanocomplex |
| Ce6 | Chlorin e6 (Photosensitizer) |
| PyroR | Pyropheophorbide-A and Resiquimod |
| ROS | Reactive oxygen species |
| CTTPA-G | (Cancer cell membranes (CC-Ms) and TTPA and Glutamine) |
| Type I AIE photosensitizer (TTPA): AIE | Aggregation Induced Emission |
| TTPA | Terephthalic acid |
| Pep-PAPM | (peptide PEP-associated protein micelles) |
| PEP | Phosphoenolpyruvate |
| TNBC | Triple-negative breast cancer |
| 231MARS | 231 membrane artesunate |
| PLGA | Poly(lactic-co-glycolic acid) |
| SK | Shikonin |
| TGF-β | Tumour Growth Factor-β |
| 5-ASA | (5-aminosalicylic acid) |
| DOX | Doxorubicin |
| IR783 | Near-infrared heptamethine cyanine dye |
| mTOR | mammalian Target of Rapamycin |
| CTL | Cytotoxic T lymphocyte |
| BMS/RA@CC Liposome | (BMS-202/RA-V@CT26 cancer cells biomimetic) |
| BMS202 | PD-1/PD-L1 inhibitor 2 |
| RA-V | Deoxybouvardin (Chemotherapeutic drug) |
| MGTe | Fusing TM and BM on the surface of glutathione (GSH) decorated Te nanoparticles (GTe) |
| TM | Tumour cell membrane |
| BM | Bacterial cell membrane |
| APC | Antigen-presenting cells |
| PGA | Poly (glycolic acid) |
| IFN | Interferon |
| mAb | monoclonal antibody |
| HSP 70/90 | Heat shock protein 70/90 |
| MHC-I/II | Major Histocompatibility Complex-I/II |
| TGF β | Tumour growth factor |
| EZH2 | Enhancer of zeste homolog 2 |
| LPS | Lipopolysaccharide |
| TLR | Toll-like receptor |
| MUC1 | Mucin 1 |
| Dex | Dexamethasone |
| ZNPs/I@CML | ZSTK carrier-free nanoparticle/Indomethacin@cancer-derived membrane/liposome |
| PI3K | Phosphoinositide 3-kinase |
| PLG | Poly(DL-Lactide-co-Glycolide) |
| ZSTK | ZSTK474 (PI3K inhibitor) |
| MCP 1 | Monocyte chemoattractant protein-1 |
| TNF 2 | Tumour necrosis factor |
| UPP | Unripe plantain peel |
| OVA | Ovalbumin |
| YP and Er NaY/GdF4 | Yttrium phosphide and Erbium Sodium;Yttrium/Gadolinium fluoride |
| UCNPs | Up conversion nanoparticles |
| iRGD peptide | 9-amino acid cyclic peptide (sequence: CRGDKGPDC) |
| NSCLC | Non-small cell lung cancer |
| PCL | Polycaprolactone |
| CaCO3 | Calcium carbonate |
| EPC | Egg yolk phosphatidylcholine |
| Span85 | Sorbitan trioleate |
| GM-CSF | Granulocyte-macrophage colony-stimulating factor |
| ODN | oligodeoxynucleotides |
| CS/γ-PGA | (Chitosan/Poly(gamma glutamic acid)) |
| IgG | Immunoglobulin G |
| CTX | cyclophosphamide |
| PLEL | poly(d,l-lactide)-poly(ethylene glycol)-poly(d,l-lactide) |
| HPAA | Hydroxyphosphono-Acetic Acid |
| PpASE | PEG-poly (AGE-Suc) with etiphosphate |
| ANLs | Synthetic long peptides |
| ANSs | MHC-I epitope restricted peptides |
| Mn-NP | Manganese nanoparticle |
| cGAS | cyclic GMP-AMP Synthase |
| STING | Stimulation of interferon genes |
| s.c. | Subcutaneous |
| i.v. | Intravenous |
| DGBA | Guanidinobenzoic acid |
| NLRP3 | NLR (Nod-like receptor) family pyrin domain containing 3 |
| iNOS | Inducible nitric oxide synthase |